You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 1100 Immunovirotherapy with the codon-modified influenza virus CodaLytic™ modulates the quality of the tumor immune infiltrate in support of anti-tumor immunity

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1100 Immunovirotherapy with the codon-modified influenza virus CodaLytic™ modulates the quality of the tumor immune infiltrate in support of anti-tumor immunity

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 202315808
Dec 20233009
Jan 20243904
Feb 20243203
Mar 202424026
Apr 20242608
May 20241601
Jun 20242003
Jul 2024404
Aug 20241402
Sep 20243004
Oct 2024805
Nov 20241406
Dec 2024405
Jan 202513015
Feb 2025003
Mar 2025008
Apr 2025005
May 2025006
Jun 2025002
Total4320127